Research analysts at StockNews.com started coverage on shares of Ultralife (NASDAQ:ULBI – Get Rating) in a research report issued on Wednesday. The brokerage set a “buy” rating on the technology company’s stock.
Ultralife Trading Down 2.7 %
Ultralife stock opened at $4.01 on Wednesday. The company has a current ratio of 2.73, a quick ratio of 1.31 and a debt-to-equity ratio of 0.17. The firm has a market cap of $64.72 million, a PE ratio of -401.00 and a beta of 1.29. The stock’s 50 day simple moving average is $4.03 and its two-hundred day simple moving average is $4.20. Ultralife has a 12 month low of $3.67 and a 12 month high of $5.77.
Ultralife (NASDAQ:ULBI – Get Rating) last issued its earnings results on Thursday, March 2nd. The technology company reported $0.04 earnings per share (EPS) for the quarter. The company had revenue of $36.11 million during the quarter. Ultralife had a positive return on equity of 0.41% and a negative net margin of 0.22%.
Institutional Inflows and Outflows
About Ultralife
Ultralife Corp. engages in the manufacture and sale of products for power solutions. It operates through the Battery & Energy Products and Communications System segments. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, thin cell and various other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems, and accessories such as cables.
See Also
- Get a free copy of the StockNews.com research report on Ultralife (ULBI)
- Do Bank Stocks Go Up When Interest Rates Rise?
- How to Invest in Vertical Farming Stocks
- Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding
- Ecolab: Slow And Steady Wins The RaceĀ
- MGM’s Hot Hand Is All In For A Rally, After This Small Break
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.